Ozempic and Wegovy, used for diabetes and weight loss, are now linked to a rare eye condition called NAION, or "eye stroke." ...

This is the first time a regulator has confirmed the side effect. Read more at straitstimes.com. Read more at straitstimes.com.

The European Medicines Agency's safety committee has concluded that a potentially dangerous eye condition is a very rare side ...

A nomogram using ocular hemodynamics and clinical factors accurately predicts ischemic stroke risk, offering a novel tool for ...

Treatment should be stopped if nonarteritic anterior ischemic optic neuropathy, which can cause vision loss, is diagnosed.

A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...

When treating an ischemic stroke – where a clot is blocking the flow of oxygen to the brain – every minute counts.

Given the evidence, the committee has recommended that the labels for Novo Nordisk’s Wegovy and Ozempic be updated to include ...

Semaglutide drugs now include rare vision risk warning as studies link long-term use to optic neuropathy, macular ...

Novo Nordisk's (NVO) weight loss drug semaglutide (Ozempic, Wegovy, Rybelsus) is linked to a rare eye condition called NAION ...